Cargando…

Prognostic/predictive markers in systemic therapy resistance and metastasis in breast cancer

Breast cancer is a highly heterogeneous group of diseases posing a significant challenge in biomarker-driven research and the development of effective targeted therapies. Especially the treatment of metastatic breast cancer poses even more challenges, as we still lose more than 42,000 women and men...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hobbs, Evthokia A., Chen, Natalie, Kuriakose, Alphi, Bonefas, Elizabeth, Lim, Bora
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290149/ https://www.ncbi.nlm.nih.gov/pubmed/35860831 http://dx.doi.org/10.1177/17588359221112698

Ejemplares similares

Real-World Evaluation of Disease Progression After CDK 4/6 Inhibitor Therapy in Patients With Hormone Receptor-Positive Metastatic Breast Cancer
por: West, Malinda T, et al.
Publicado: (2023)

Impact of TP53 mutations in Triple Negative Breast Cancer
por: Mitri, Zahi I., et al.
Publicado: (2022)

The Potential Prognostic Marker TyG Index Predicts Time to Brain Metastasis at HER2 Positive Breast Cancer
por: Karadag, Ibrahim, et al.
Publicado: (2023)

The impact of HER2-directed targeted therapy on HER2-positive DCIS of the breast
por: Lewis, Gary. D., et al.
Publicado: (2021)

Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis
por: Wu, Yi-Ying, et al.
Publicado: (2010)

PTK 7 Is a Transforming Gene and Prognostic Marker for Breast Cancer and Nodal Metastasis Involvement
por: Gärtner, Silvia, et al.
Publicado: (2014)

PARPBP is a prognostic marker and confers anthracycline resistance to breast cancer
por: Chen, Bo, et al.
Publicado: (2020)

Long non-coding RNA expression profiles predict metastasis in lymph node-negative breast cancer independently of traditional prognostic markers
por: Sørensen, Kristina P, et al.
Publicado: (2015)

Laboratory Models for Investigating Breast Cancer Therapy Resistance and Metastasis
por: Roarty, Kevin, et al.
Publicado: (2021)

Mitochondrial markers predict recurrence, metastasis and tamoxifen-resistance in breast cancer patients: Early detection of treatment failure with companion diagnostics
por: Sotgia, Federica, et al.
Publicado: (2017)

Prognostic and Predictive Markers in Cancer
por: Conley, Barbara A., et al.
Publicado: (2004)

Prognostic and Clinicopathological Correlations of Cell Cycle Marker Expressions before and after the Primary Systemic Therapy of Breast Cancer
por: Tőkés, Tímea, et al.
Publicado: (2019)

Bone Metastasis Prognostic Factors in Breast Cancer
por: Yazdani, Akram, et al.
Publicado: (2019)

Predictive and prognostic biomarkers of bone metastasis in breast cancer: current status and future directions
por: Wang, Shenkangle, et al.
Publicado: (2023)

Therapy resistance and metastasis
por: Sleeman, Jonathan P.
Publicado: (2023)

Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance
por: Taneja, Pankaj, et al.
Publicado: (2010)

PTK7 as a potential prognostic and predictive marker of response to adjuvant chemotherapy in breast cancer patients, and resistance to anthracycline drugs
por: Ataseven, Beyhan, et al.
Publicado: (2014)

Identification and validation of DNA methylation markers to predict axillary lymph node metastasis of breast cancer
por: Luo, Jianguo, et al.
Publicado: (2022)

Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
por: Giuliano, Mario, et al.
Publicado: (2011)

Identification of high-quality cancer prognostic markers and metastasis network modules
por: Li, Jie, et al.
Publicado: (2010)

ALDH1 as a prognostic marker for lymph node metastasis in OSCC
por: Götz, Carolin, et al.
Publicado: (2018)

BAP1 methylation: a prognostic marker of uveal melanoma metastasis
por: Bakhoum, Mathieu F., et al.
Publicado: (2021)

Prognostic value of systemic inflammatory markers and development of a nomogram in breast cancer
por: Cho, Uiju, et al.
Publicado: (2018)

Mena(calc), a quantitative method of metastasis assessment, as a prognostic marker for axillary node-negative breast cancer
por: Forse, Catherine L., et al.
Publicado: (2015)

Poziotinib Inhibits HER2-Mutant–Driven Therapeutic Resistance and Multiorgan Metastasis in Breast Cancer
por: Kalra, Rashi, et al.
Publicado: (2022)

Prognostic and Predictive Molecular Markers in Cholangiocarcinoma
por: Pavicevic, Sandra, et al.
Publicado: (2022)

β1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer
por: Yin, Hsin-Ling, et al.
Publicado: (2016)

FOXA1 in Breast Cancer: A Luminal Marker with Promising Prognostic and Predictive Impact
por: Metovic, Jasna, et al.
Publicado: (2022)

Sexually Dimorphic Alterations in the Transcriptome and Behavior with Loss of Histone Demethylase KDM5C
por: Bonefas, Katherine M., et al.
Publicado: (2023)

Prognostic factors of breast cancer liver metastasis surgery
por: Treska, Vladislav, et al.
Publicado: (2015)

A Prognostic Model for Breast Cancer With Liver Metastasis
por: Ji, Lei, et al.
Publicado: (2020)

Prognostic molecular markers in early breast cancer
por: Esteva, Francisco J, et al.
Publicado: (2004)

RECK is not an independent prognostic marker for breast cancer
por: Gomes, Luciana R., et al.
Publicado: (2015)

An assessment of prognostic immunity markers in breast cancer
por: Yang, Benlong, et al.
Publicado: (2018)

Phosphorylation of androgen receptors at serine 515 is a potential prognostic marker for triple negative breast cancer
por: Roseweir, Antonia K., et al.
Publicado: (2017)

Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer
por: Fernandez-Garcia, Daniel, et al.
Publicado: (2019)

ESR1 fusions drive endocrine therapy resistance and metastasis in breast cancer
por: Lei, Jonathan T., et al.
Publicado: (2018)

Current treatment of early breast cancer: adjuvant and neoadjuvant therapy
por: Miller, Elizabeth, et al.
Publicado: (2014)

Circulating miR-200 family as predictive markers during systemic therapy of metastatic breast cancer
por: Fischer, Chiara, et al.
Publicado: (2022)

Serum S100B, Lactate Dehydrogenase and Brain Metastasis Are Prognostic Factors in Patients with Distant Melanoma Metastasis and Systemic Therapy
por: Weide, Benjamin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fkmt9vg974l4qkliledbur7nvu